Softened food reduces weight loss in the streptozotocin-induced male mouse model of diabetic nephropathy

Sisse A Nørgaard, Fredrik W Sand, Dorte B Sørensen, Klas Sp Abelson, Henrik Søndergaard

7 Citations (Scopus)

Abstract

The streptozotocin (STZ)-induced diabetic mouse is a widely used model of diabetes and diabetic nephropathy (DN). However, it is a well-known issue that this model is challenged by high weight loss, which despite supportive measures often results in high euthanization rates. To overcome these issues, we hypothesized that supplementing STZ-induced diabetic mice with water-softened chow in addition to normal chow would reduce weight loss, lower the need for supportive treatment, and reduce the number of mice reaching the humane endpoint of 20% weight loss. In a 15 week STZ-induced DN study we demonstrated that diabetic male mice receiving softened chow had reduced acute weight loss following STZ treatment ( p = 0.045) and additionally fewer mice were euthanized due to weight loss. By supplementing the diabetic mice with softened chow, no mice reached 20% weight loss whereas 37.5% of the mice without this supplement reached this humane endpoint ( p = 0.0027). Excretion of corticosterone metabolites in faeces was reduced in diabetic mice on softened chow ( p = 0.0007), suggesting lower levels of general stress. Finally, it was demonstrated that the water-softened chow supplement did not significantly affect the induction of key disease parameters, i.e. %HbA1C and albuminuria nor result in abnormal teeth wear. In conclusion, supplementation of softened food is refining the STZ-induced diabetic mouse model significantly by reducing stress, weight loss and the number of animals sacrificed due to humane endpoints, while maintaining the key phenotypes of diabetes and nephropathy.

Original languageEnglish
JournalLaboratory Animals
Volume52
Issue number4
Pages (from-to)373-383
ISSN0023-6772
DOIs
Publication statusPublished - 1 Aug 2018

Fingerprint

Dive into the research topics of 'Softened food reduces weight loss in the streptozotocin-induced male mouse model of diabetic nephropathy'. Together they form a unique fingerprint.

Cite this